BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27793116)

  • 1. The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.
    Sobhonslidsuk A; Poovorawan K; Soonthornworasiri N; Pan-Ngum W; Phaosawasdi K
    BMC Gastroenterol; 2016 Oct; 16(1):135. PubMed ID: 27793116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study.
    Thanapirom K; Treeprasertsuk S; Soonthornworasiri N; Poovorawan K; Chaiteerakij R; Komolmit P; Phaosawasdi K; Pinzani M
    BMC Gastroenterol; 2019 Jan; 19(1):18. PubMed ID: 30691414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on drug induced liver injury.
    Rangnekar AS; Fontana RJ
    Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.
    Devarbhavi H; Dierkhising R; Kremers WK; Sandeep MS; Karanth D; Adarsh CK
    Am J Gastroenterol; 2010 Nov; 105(11):2396-404. PubMed ID: 20648003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
    Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
    Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
    Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
    J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced liver injury in Australia, 2009-2020: the increasing proportion of non-paracetamol cases linked with herbal and dietary supplements.
    Nash E; Sabih AH; Chetwood J; Wood G; Pandya K; Yip T; Majumdar A; McCaughan GW; Strasser SI; Liu K
    Med J Aust; 2021 Sep; 215(6):261-268. PubMed ID: 34272737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis.
    Tomich LG; Núñez M; Mendes-Correa MC
    Ann Hepatol; 2015; 14(6):888-94. PubMed ID: 26436361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
    Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
    J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis.
    Nguyen GC; Sam J; Thuluvath PJ
    Hepatology; 2008 Oct; 48(4):1336-41. PubMed ID: 18821593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study.
    Gulmez SE; Unal US; Lassalle R; Chartier A; Grolleau A; Moore N
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1174-1181. PubMed ID: 30112779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antituberculous drug-induced liver injury: current perspective.
    Devarbhavi H
    Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supratherapeutic dosing of acetaminophen among hospitalized patients.
    Zhou L; Maviglia SM; Mahoney LM; Chang F; Orav EJ; Plasek J; Boulware LJ; Bates DW; Rocha RA
    Arch Intern Med; 2012 Dec; 172(22):1721-8. PubMed ID: 23401887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced liver injury: a summary of recent advances.
    Stine JG; Lewis JH
    Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):875-90. PubMed ID: 21510822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpatient admissions for drug-induced liver injury: results from a single center.
    Carey EJ; Vargas HE; Douglas DD; Balan V; Byrne TJ; Harrison ME; Rakela J
    Dig Dis Sci; 2008 Jul; 53(7):1977-82. PubMed ID: 18392678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and risk factors of drug induced liver disease: a survey based study in pharmacies].
    Jüngst C; Gräber S; Klahn D; Wedemeyer H; Lammert F
    Z Gastroenterol; 2016 Feb; 54(2):131-8. PubMed ID: 26854832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure.
    Cholongitas E; Theocharidou E; Vasianopoulou P; Betrosian A; Shaw S; Patch D; O'Beirne J; Agarwal B; Burroughs AK
    Liver Transpl; 2012 Apr; 18(4):405-12. PubMed ID: 22213443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.